Analysed LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) News Sources
LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year
31-03-2026
yahoo.com
LIXTE Biotechnology (LIXT) Has the World's Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes
01-04-2026
yahoo.com
LIXTE Biotechnology Holdings (LIXT) Files 2025 Form 10-K, Highlights Transformational Year
02-04-2026
yahoo.com
Lixte Biotech Holdings (LIXT) Advances Precision Oncology Strategy With LB-100, Expands Clinical and Strategic Partnerships
10-04-2026
yahoo.com
Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference
13-04-2026
yahoo.com
LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
13-04-2026
yahoo.com
Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built
17-04-2026
yahoo.com
LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape
20-04-2026
yahoo.com
LIXTE Biotechnology Holdings (LIXT) Unlocking New Potential in Precision Cancer Treatment
27-04-2026
yahoo.com
What is the current price of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ)?
The current price of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) is $6.34.
LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) since the previous trading day is $0.69.
LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) since the previous trading day is 12.2124%.
What is the most recent average sentiment score for LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ)?
The most recent average sentiment score for LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ)?
The most recent sentiment for LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ) is .
SEC-8K** Filing Available For LIXTE BIOTECHNOLOGY HOLDINGS (LIXT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.